ZIM
AGL icon

Zacks Investment Management’s Agilon Health AGL Stock Holding History

Zacks Investment Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-935
Closed -$293K – 636
2023
Q4 		$293K Hold
935
– – ﹤0.01% 531
2023
Q3 		$415K Hold
935
– – 0.01% 473
2023
Q2 		$405K Buy
+935
New +$525K 0.01% 485

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Zacks Investment Management's AGL Position: Q1 2024 in Review

Zacks Investment Management sold out of Agilon Health (AGL) in Q1 2024, closing a stake of 935 shares — an estimated $293K sold.

Zacks Investment Management first reported a position in AGL in Q2 2023 and held it in 3 quarters. The position peaked at $415K in Q3 2023. 198 funds tracked by Wall St. Rank hold AGL as of Q1 2024.

  • Zacks Investment Management reported no remaining Agilon Health position as of Q1 2024 after selling out during the quarter.
  • Zacks Investment Management sold 935 Agilon Health shares in Q1 2024, an estimated $293K.
  • Zacks Investment Management first reported a position in Agilon Health in Q2 2023 and held it in 3 quarters.
  • Zacks Investment Management's Agilon Health position peaked at $415K in Q3 2023.
  • 198 funds tracked by Wall St. Rank held Agilon Health as of Q1 2024.

Based on Zacks Investment Management's 13F filing for Q1 2024, filed 15 May 2024.